Hopes that the first drugs shown to slow Alzheimer’s disease could be rolled out on the NHS have risen after a second manufacturer entered price negotiations. US drugmaker Eli Lilly and Company, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results